Background: Hemifacial spasm (HFS) is a common disorder and has a significant impact on the quality of life. Microvascular decompression (MVD) is an effective and safe treatment option for patients with HFS, however the effectiveness and safety of MVD in elderly patients with HFS is not clear. Methods: We enrolled 699 HFS patients who underwent MVD from February 2008 to December 2011 at the Samsung Medical Center in Seoul, Korea. Subjects were divided into two groups: an elderly group (patients who were 60 years old or older) and a younger group. We compared demographic and clinical data, surgical outcome and complications after MVD between the groups. Results: The elderly group had more severe spasms and higher grade indentation than the younger group. Multiple offending vessels were more commonly detected in the elderly group. Although the improvement was similar 6 months after MVD between the groups, complications were more common in the elderly group even after controlling for possible confounding factors. In particular, ear problems including hearing loss were more common in the elderly group. Conclusion: MVD is an effective treatment option in elderly patients with HFS. However, surgeons should be pay attention to potential complications in elderly patients with HFS.

Keywords:
Hemifacial spasm, Microvascular decompression, Safety, Efficacy, Elderly
1.
Wang A, Jankovic J: Hemifacial spasm: clinical findings and treatment. Muscle Nerve 1998;21:1740-1747.
2.
Rudzinska M, Wojcik M, Malec M, Grabska N, Szubiga M, Hartel M, Szczudlik A: Factors affecting the quality of life in hemifacial spasm patients. Neurol Neurochir Pol 2012;46:121-129.
3.
Jannetta PJ: Observations on the etiology of trigeminal neuralgia, hemifacial spasm, acoustic nerve dysfunction and glossopharyngeal neuralgia. Definitive microsurgical treatment and results in 117 patients. Neurochirurgia (Stuttg) 1977;20:145-154.
4.
Gardner WJ: Concerning the mechanism of trigeminal neuralgia and hemifacial spasm. J Neurosurg 1962;19:947-958.
5.
Mauriello JA Jr, Leone T, Dhillon S, Pakeman B, Mostafavi R, Yepez MC: Treatment choices of 119 patients with hemifacial spasm over 11 years. Clin Neurol Neurosurg 1996;98:213-216.
6.
Gil Polo C, Rodriguez Sanz MF, Berrocal Izquierdo N, Castrillo Sanz A, Gutierrez Rios R, Zamora Garcia MI, Mendoza Rodriguez A, Duarte Garcia-Luis J: Blepharospasm and hemifacial spasm: long-term treatment with botulinum toxin. Neurologia 2013;28:131-136.
7.
Zhu J, Li ST, Zhong J, Ying TT, Guan HX, Yang XS, Zhou QM, Jiao W: Microvascular decompression for hemifacial spasm. J Craniofac Surg 2012;23:1385-1387.
8.
Hyun SJ, Kong DS, Park K: Microvascular decompression for treating hemifacial spasm: lessons learned from a prospective study of 1,174 operations. Neurosurg Rev 2010;33:325-334; discussion 334.
9.
Huh R, Han IB, Moon JY, Chang JW, Chung SS: Microvascular decompression for hemifacial spasm: analyses of operative complications in 1,582 consecutive patients. Surg Neurol 2008;69:153-157; discussion 157.
10.
Gunther T, Gerganov VM, Stieglitz L, Ludemann W, Samii A, Samii M: Microvascular decompression for trigeminal neuralgia in the elderly: long-term treatment outcome and comparison with younger patients. Neurosurgery 2009;65:477-482; discussion 482.
11.
Sekula RF Jr, Frederickson AM, Jannetta PJ, Quigley MR, Aziz KM, Arnone GD: Microvascular decompression for elderly patients with trigeminal neuralgia: a prospective study and systematic review with meta-analysis. J Neurosurg 2011;114:172-179.
12.
Rughani AI, Dumont TM, Lin CT, Tranmer BI, Horgan MA: Safety of microvascular decompression for trigeminal neuralgia in the elderly. Clinical article. J Neurosurg 2011;115:202-209.
13.
Jeon CJ, Kong DS, Lee JA, Park K: The efficacy and safety of microvascular decompression for hemifacial spasm in elderly patients. J Korean Neurosurg Soc 2010;47:442-445.
14.
Ashkan K, Marsh H: Microvascular decompression for trigeminal neuralgia in the elderly: a review of the safety and efficacy. Neurosurgery 2004;55:840-848; discussion 848-850.
15.
Lee JA, Jo KW, Kong DS, Park K: Using the new clinical grading scale for quantification of the severity of hemifacial spasm: correlations with a quality of life scale. Stereotact Funct Neurosurg 2012;90:16-19.
16.
Jo KW, Kong DS, Park K: Microvascular decompression for hemifacial spasm: long-term outcome and prognostic factors, with emphasis on delayed cure. Neurosurg Rev 2013;36:297-301.
17.
House JW, Brackmann DE: Facial nerve grading system. Otolaryngol Head Neck Surg 1985;93:146-147.
18.
Jo KW, Kim JW, Kong DS, Hong SH, Park K: The patterns and risk factors of hearing loss following microvascular decompression for hemifacial spasm. Acta Neurochir (Wien) 2011;153:1023-1030.
19.
Park K, Hong SH, Hong SD, Cho YS, Chung WH, Ryu NG: Patterns of hearing loss after microvascular decompression for hemifacial spasm. J Neurol Neurosurg Psychiatry 2009;80:1165-1167.
20.
Chen YC, Thaler D, Nixon PD, Stern CE, Passingham RE: The functions of the medial premotor cortex. II. The timing and selection of learned movements. Exp Brain Res 1995;102:461-473.
21.
Polo G, Fischer C, Sindou MP, Marneffe V: Brainstem auditory-evoked potential monitoring during microvascular decompression for hemifacial spasm: intraoperative brainstem auditory-evoked potential changes and warning values to prevent hearing loss - prospective study in a consecutive series of 84 patients. Neurosurgery 2004;54:97-104; discussion 104-106.
22.
Copeland B: Microvascular decompression for trigeminal neuralgia in the elderly: a review of the safety and efficacy. Neurosurgery 2006;58:E799; author reply E799.
23.
Thirumala PD, Shah AC, Nikonow TN, Habeych ME, Balzer JR, Crammond DJ, Burkhart L, Chang YF, Gardner P, Kassam AB, Horowitz MB: Microvascular decompression for hemifacial spasm: evaluating outcome prognosticators including the value of intraoperative lateral spread response monitoring and clinical characteristics in 293 patients. J Clin Neurophysiol 2011;28:56-66.
24.
Li J, Zhang Y, Zhu H, Li Y: Prognostic value of intraoperative abnormal muscle response monitoring during microvascular decompression for long-term outcome of hemifacial spasm. J Clin Neurosci 2012;19:44-48.
25.
Kim CH, Kong DS, Lee JA, Kwan P: The potential value of the disappearance of the lateral spread response during microvascular decompression for predicting the clinical outcome of hemifacial spasms: a prospective study. Neurosurgery 2010;67:1581-1587; discussion 1587-1588.
26.
Kim HR, Rhee DJ, Kong DS, Park K: Prognostic factors of hemifacial spasm after microvascular decompression. J Korean Neurosurg Soc 2009;45:336-340.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.